The Management of Metastatic Castrate-Sensitive Prostate Cancer: …
This commentary highlights 2 international studies on real-world treatment trends and patterns among patients with metastatic castration-sensitive and resistant prostate cancer and how interventions …
Treatments for metastatic castration-sensitive prostate cancer
Metastatic castration-sensitive prostate cancer (CSPC) can be treated with hormone therapy, radiation therapy and chemotherapy.
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
May 31, 2019 · The initial treatment for metastatic prostate cancer is androgen-deprivation therapy (ADT) through medical or surgical castration. In the past few years, results from several large, …
Advances in the Treatment and Management of Metastatic Castration ...
Sep 28, 2023 · Metastatic castration-sensitive prostate cancer (mCSPC), also referred to as metastatic hormone-sensitive prostate cancer (mHSPC), is an advanced form of prostate cancer defined by …
Emerging Evidence-Based Treatment Strategies in Metastatic Castration ...
4 days ago · Patients with Metastatic Castration-Resistant Prostate Cancer Today: Unmet Needs and Treatment Goals Rana McKay McKay opened this symposium by describing the natural history of …
Treatment for Metastatic Prostate Cancer Often Suboptimal
Feb 18, 2025 · In most people with metastatic hormone-sensitive prostate cancer, the cancer eventually changes so that it can grow without being reliant on testosterone from the testes, known as hormone …
FDA approves darolutamide for metastatic castration-sensitive prostate ...
On June 3, 2025, the Food and Drug Administration (FDA) approved darolutamide (Nubeqa, Bayer Healthcare Pharmaceuticals Inc.) for metastatic castration-sensitive prostate cancer (mCSPC).
How We Treat Metastatic Castration-Sensitive Prostate Cancer
Aug 16, 2024 · Risk Stratifying Metastatic Castration-Sensitive Prostate Cancer Among the numerous available strategies, the best choice of first-line therapy for mCSPC is a contentious matter, primarily …
Current management of metastatic castration-sensitive prostate cancer
Jan 1, 2021 · The treatment for metastatic castration-sensitive prostate cancer (mCSPC) has evolved rapidly over the last decade with the addition of upfront intensification with novel hormonal therapies …
Initial systemic therapy for advanced, recurrent, and metastatic ...
Jun 11, 2025 · The role and timing of systemic therapy for males with an isolated biochemical recurrence after local definitive prostate cancer are discussed elsewhere, as is an overview of treatment for …